Skip to product information
1 of 1

Pure Lab Vitamins



Regular price $53.99 USD
Regular price Sale price $53.99 USD
Sale Sold out
Shipping calculated at checkout.


About CoQ10+NADH

NADH+Ubiquinol provides an energy boost to every cell in the body, but especially to the heart and brain—where the highest concentrations of these two important coenzymes are found. Individuals within different cohorts have been shown to benefit from the combined energizing effect of these nutrients.  Studies performed by Dr. G.D. Birkmayer and team have shown some impressive results with just 20 milligrams of daily NADH supplementation in athletes. Participants found less lactic acid-related muscle fatigue after prolonged activity. This means that athletes could perform longer, and the recovery period between training sessions could be shorter, with the same rejuvenating results obtained from a longer rest period.  Second, users found 7% more energy, which is likely due to the fact that NADH triggers ATP production---the basic energy source of all cells.

Individuals who are concerned about neurodegenerative diseases or cognitive impairment may also benefit from CoQ10 and NADH supplementation. NADH has been studied globally for its potential in Parkinson’s and Alzheimer’s. A large Austrian study demonstrated that oral supplementation of NADH improved dopamine production in almost 80% of the Parkinson’s patients involved. NADH has shown promise in the treatment of Chronic Fatigue Syndrome (CFS).

The effects of CoQ10 deficiency have been well documented in CFS, resulting in inflammation, oxidative stress and mitochondrial dysfunction. In a study of 26 CFS patients, 31% showed a significant reduction in fatigue after NADH supplementation. Meanwhile, a larger study involving 58 patients (30 females, 28 males) suffering from a variety of typical fatigue illnesses such as CFS, Lyme Disease, Fibromyalgia and Gulf War illness showed a 30.7% reduction in overall fatigue within 60 days of NADH treatment. (P < 0.001).

As an antioxidant, CoQ10 is a well-known cardiovascular protectant that is depleted cholesterol-lowering statin drugs.  A meta-analysis of over twenty CoQ10 studies concluded that use of the supplemental form of the nutrient has the potential to lower blood pressure without any significant side effects. These are just two ways how the combination of ubiquinol and NADH provides protection for those with cardiovascular concerns.

Conditions that may benefit from NADH+Ubiquinol include:

•neurodegenerative conditions, Parkinson’s, Dementia, Alzheimer’s, MS, ALS

•Chronic Fatigue Syndrome

•Low Stamina/Endurance

•Post Traumatic Stress

•Poor Memory/Concentration

•Lyme Disease


•High Cholesterol

•Low Energy


•High Blood Pressure


Medicinal Ingredients (per capsule):
NADH 10mg (reduced Nicotinamide Adenine Dinucleotide), Kaneka® Ubiquinol 40mg.

Non-Medicinal Ingredients:
100% vegi-caps, Cellulose, Magnesium Stearate (veg source).

Contains No:
Gluten, wheat, sugar, yeast, milk, egg, shellfish, soy, corn, or preservatives. No artificial colours. Product is vegan and halal.


CoQ10+NADH References

Aguiló A, Tauler P, Sureda A, Cases N, Tur J, Pons A. Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen. Journal of Sports Sciences. 2007;25:1203–10.

Alf D1Schmidt ME2Siebrecht SC3.  Ubiquinol supplementation enhances peak power production in trained athletes: a double-blind, placebo controlled study.  J Int Soc Sports Nutr. 2013 Apr 29;10:24. doi: 10.1186/1550-2783-10-24.

 Birkmayer JG, Vrecko C, Volc D, Birkmayer W. Nicotinamide adenine dinucleotide (NADH)--a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application. Acta Neurologica Scandinavica. Supplementum. 1993 ;146:32-35.

Birkmayer GD. Stabilized NADH improves the physical and mental performance in highly conditioned athletes. Proceedings from the First International Conference on the Mechanism of Action of Nutraceuticals, Dubrovnik, Croatia, October 2001.

Birkmayer GJ, Birkmayer W. Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH). Acta Neurol Scand Suppl. 1989;126:183-7.

Castro-Marrero, Jesus et al. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome – A randomized, controlled, double-blind trial.  Clinical Nutrition 35:4;Aug.2016, 826-834.

Deichmann R, Lavie C, Andrews S. Coenzyme Q10 and statin-induced mitochondrial dysfunction. Ochsner J. 2010;10(1):16-21.

Frei B, Kim MC, Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci U S A. 1990;87(12):4879‐4883.

Lee BJ, Lin YC, Huang YC, Ko YW, Hsia S, Lin PT. The relationship between coenzyme Q10, oxidative stress, and antioxidant enzymes activities and coronary artery disease.ScientificWorldJournal. 2012;2012:792756.

  Nicolson GL, Settineri R, Ellithorpe R. Lipid replacement therapy with a glycophospholipid formulation with NADH and CoQ10 significantly reduces fatigue in intractable chronic fatiguing illnesses and chronic Lyme disease patients. Int J Clin Med. 2012;3(3):163–170.

Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007 Apr;21(4):297-306.

Vrecko K, Storga D, Birkmayer JG, Möller R, Tafeit E, Horejsi R, Reibnegger G. NADH stimulates endogenous dopamine biosynthesis by enhancing the recycling of tetrahydrobiopterin in rat phaeochromocytoma cells. Biochim Biophys Acta. 1997 Jul 10;1361(1):59-65.

View full details